-The Business Standard Chennai: The Intellectual Property Appellate Board (IPAB) today upheld a compulsory licence issued by the Controller of Patents to Hyderabad-based Natco Pharma Ltd, a generic drug maker, to manufacture and sell a cancer drug of Bayer Corp in India. IPAB, however, made changes in the licence order by increasing the royalty payment to Bayer Corp for Nexavar, used to treat liver and kidney cancer, from six per cent to...

-The Indian Express Verma panel wants criminal trial for armed forces men in rape cases. A look at some such cases in Kashmir One of the key recommendations of the Justice J S Verma Committee has been that sexual offences by armed forces personnel be brought under ordinary criminal law. In Kashmir, the armed forces have frequently sought — and got — immunity from prosecution in civilian courts after their personnel have had...

-Live Mint Court says legal, ethical issues involved; directs govt to monitor and regulate clinical trials of all experimental drugs  The Supreme Court directed the health ministry to monitor and regulate all clinical trials of experimental drugs in the country until further notice and observed that unregulated trials have caused “havoc”. The apex court order on Thursday revoked the power of the Central Drugs Standard Control Organization under the Drugs Controller General of...

-The Indian Express Notwithstanding the recent Supreme Court judgment re-drawing their eligibility criteria, Attorney General G E Vahanvati has said that the central and state information commissioners can continue for now. According to him, the SC ruling will be operative with prospective effect, but the government should not delay its review petition as the apex court’s decision is capable of creating “disarray” in their functioning. In his opinion submitted to the government...

-The Economic Times MUMBAI: In a victory to generic drugmakers, the Intellectual Property Appellate Board (IPAB) of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmaker Natco. The Compulsory Licence (CL) issued by the Controller of Patents in March this year allowed Natco to make and sell a generic version of Nexavar - used for treating liver and kidney cancer - at...